SEM · As filed with the SEC
Select Medical Holdings income statement, by quarter
The statement as Select Medical Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations (unaudited) · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1,421,476 | 1,396,634† | 1,363,445 | 1,339,579 | 1,353,172 | 1,312,564† |
| Costs and expenses: | ||||||
| Cost of services, exclusive of depreciation and amortization | 1,246,008 | 1,250,800† | 1,215,995 | 1,184,129 | 1,172,611 | 1,175,099† |
| General and administrative | 39,384 | 45,693† | 40,050 | 35,663 | 33,008 | 80,197† |
| Depreciation and amortization | — | 36,205† | 34,442 | 34,848 | 34,808 | 36,283† |
| Depreciation and amortization | 37,666 | — | — | — | — | — |
| Total costs and expenses | 1,323,058 | 1,332,698† | 1,290,487 | 1,254,640 | 1,240,427 | 1,291,579† |
| Other operating income | — | 0† | 0 | 1,592 | 0 | 106† |
| Income from operations | 98,418 | 63,936† | 72,958 | 86,531 | 112,745 | 21,091† |
| Other income and expense: | ||||||
| Loss on early retirement of debt | — | 0† | 0 | — | — | (17,906)† |
| Equity in earnings of unconsolidated subsidiaries | — | 15,399† | 12,992 | 13,618 | 12,512 | 10,423† |
| Equity in earnings of unconsolidated subsidiaries | 12,011 | — | — | — | — | — |
| Interest expense | (28,336) | (28,871)† | (30,021) | (29,978) | (29,072) | (28,551)† |
| Income before income taxes | 82,093 | 50,464† | 55,929 | 70,171 | 96,185 | (14,943)† |
| Income tax expense | 18,318 | 12,722† | 11,749 | 12,292 | 21,453 | (4,487)† |
| Income from continuing operations, net of tax | — | 37,742† | 44,180 | 57,879 | 74,732 | (10,456)† |
| Income from discontinued business | — | 0† | 0 | 0 | 0 | 24,669† |
| Income tax expense from discontinued business | — | 0† | 0 | 0 | 0 | 10,457† |
| Income from discontinued operations, net of tax | — | 0† | 0 | 0 | 0 | 14,212† |
| Net income | 63,775 | 37,742† | 44,180 | 57,879 | 74,732 | 3,756† |
| Less: Net income attributable to non-controlling interests | 19,780 | 17,568† | 15,387 | 17,308 | 18,051 | 19,806† |
| Net income attributable to Select Medical Holdings Corporation | 43,995 | 20,174† | 28,793 | 40,571 | 56,681 | (16,050)† |
| Income from continuing operations, net of tax | — | 20,174† | 28,793 | 40,571 | 56,681 | (23,664)† |
| Income from discontinued operations, net of tax | — | 0† | 0 | 0 | 0 | 7,614† |
| Earnings per common share (Note 11): | ||||||
| Continuing operations - basic (in dollars per share) | — | — | 0.23 | 0.32 | 0.44 | — |
| Continuing operations - diluted (in dollars per share) | — | — | 0.23 | 0.32 | 0.44 | — |
| Discontinued operations - basic (in dollars per share) | — | — | 0.00 | 0.00 | 0.00 | — |
| Discontinued operations - diluted (in dollars per share) | — | — | 0.00 | 0.00 | 0.00 | — |
| Basic (in dollars per share) | 0.35 | — | 0.23 | 0.32 | 0.44 | — |
| Diluted (in dollars per share) | 0.35 | — | 0.23 | 0.32 | 0.44 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.